SANA BIOTECHNOLOGY, INC.

Insiders Sana Biotechnology, Inc.

Equities

SANA

US7995661045

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2024 BST			5-day change	1st Jan Change
9.27 ^USD	+7.79%		-2.32%	+127.21%

05-08	Sana Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development	04-18	CI
Viridian Therapeutics Names Jennifer Tousignant as Chief Legal Officer	02-16	MT
Sana Biotechnology Insider Bought Shares Worth $9,999,996, According to a Recent SEC Filing	02-12	MT
Sana Biotechnology Insider Bought Shares Worth $9,999,996, According to a Recent SEC Filing	02-12	MT
Sana Biotechnology Insider Sold Shares Worth $300,098, According to a Recent SEC Filing	12-18	MT
Sana Biotechnology Names Gary Meininger Chief Medical Officer	10/04/23	MT
Sana Biotechnology, Inc. Announces Executive Changes	10/04/23	CI
Insider Buy: Sana Biotechnology	17/02/23	MT
Sana Biotechnology, Inc. Announces Board Appointments	02/06/22	CI
Illumina : Appoints Bob Ragusa as GRAIL's CEO	15/10/21	MT
Insider Sell: Sana Biotechnology	17/09/21	MT
Insider Sell: Sana Biotechnology	13/09/21	MT
Geoffrey Von Maltzahn to Resign from the Board of Directors of Sana Biotechnology, Inc	03/09/21	CI
Sana Biotechnology Announces Appointments to Board of Directors	08/01/21	CI
Sana Biotechnology, Inc. Appoints Ke Liu, as Head of Regulatory Affairs & Strategy	06/01/21	CI
Sana Biotechnology, Inc. Appoints Ed Rebar as Chief Technology Officer and Terry Fry as SVP, Head of T Cell Therapeutics	03/09/20	CI
Sana Biotechnology, Inc. Appoints Stacey Ma as Executive Vice President, Technical Operations	21/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer